Vanguard Group
CADX

Vanguard Group’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Vanguard Group’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,533,008
Closed -$32M – 3976
2013
Q4 		$32M Buy
3,533,008
+149,802
+4% +$1.36M ﹤0.01% 1991
2013
Q3 		$21.3M Buy
3,383,206
+137,036
+4% +$865K ﹤0.01% 2080
2013
Q2 		$22.1M Buy
+3,246,170
New +$22.1M ﹤0.01% 2041